Pharmicell (005690) — Cash Flow Reinvestment Rate
Pharmicell (005690) has a Cash Flow Reinvestment Rate of 2.17x as of September 2025, reinvesting ₩19.07 Billion (capex ₩622.48 Million plus investments ₩-18.44 Billion) from operating cash flow of ₩8.78 Billion. Explore 005690 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pharmicell Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Pharmicell across 6 annual periods. Also explore Pharmicell asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Pharmicell (2016–2024)
Year-by-year capital reinvestment analysis for Pharmicell. For live market cap and broader valuation context, see 005690 company net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.18x | ₩11.14 Billion | ₩3.50 Billion | ₩4.34 Billion | ▲ +215.1% |
| 2023 | 1.01x | ₩11.94 Billion | ₩11.81 Billion | ₩6.02 Billion | ▼ -79.7% |
| 2022 | 4.99x | ₩39.49 Billion | ₩7.91 Billion | ₩18.96 Billion | ▲ +930.4% |
| 2020 | 0.48x | ₩4.35 Billion | ₩8.98 Billion | ₩742.73 Million | ▼ -85.5% |
| 2018 | 3.34x | ₩11.39 Billion | ₩3.40 Billion | ₩4.68 Billion | ▼ -59.7% |
| 2016 | 8.30x | ₩8.21 Billion | ₩988.97 Million | ₩3.85 Billion | — |